Daily regimen and compliance with treatment

doi:10.1136/bmj.323.7314.647

BMJ 2001;323:647 ( 22 September )

Editorials

Daily regimen and compliance with treatment

Fewer daily doses and drugs with fewer side effects improve compliance

The first 150 words of the full text of this article appear below.

Patient compliance $---$ that is, adherence to the regimen of care recommended by the doctor and persistence with it over time $---$ hasbeen a common concern in medical practice for a long time. A searchon Medline found nearly 60 000 citations since 1980 related tocompliance. Though much is known about the problem and how toovercome it, little seems to have been done in everyday medicalpractice by healthcare systems andpractitioners.

At most, 50% of people with chronic disease comply with their doctor's recommendations, irrespective of disease, treatment,or age.¹ Adherence and persistence are poor even among patientswith diseases with a high and moderate risk of death.^2-4 Manyfactors related to patients, doctors, and the medical system affectcompliance with treatment.^2-7 Similar problems exist in all countries. ⁵ ⁶ Doctors and patients are equally responsible for this abysmalstate of affairs.⁵

The disease in which adherence and persistence have been best . . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati What's this?

Relevant Articles

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories: Bernard Vrijens, Gäbor Vincze, Paulus Kristanto, John Urquhart, and Michel Burnier
BMJ 2008 336: 1114-1117. [Abstract] [Full Text] [PDF]

Daily regimen and compliance with treatment: Knut Schroeder, Shah Ebrahim, Tom Fahey, Alan Montgomery, Tim Peters, Bryan Lask, and Alan Porter
BMJ 2002 324: 425. [Extract] [Full Text]

This article has been cited by other articles:

Kato, P. M., Cole, S. W., Bradlyn, A. S., Pollock, B. H. (2008). A Video Game Improves Behavioral Outcomes in Adolescents and Young Adults With Cancer: A Randomized Trial. Pediatrics 122: e305-e317 [Abstract] [Full text]
Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., Burnier, M. (2008). Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 336: 1114-1117 [Abstract] [Full text]
Calabrese, J. R., Keck, P. E. Jr., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., The BOLDER Study Group, (2005). A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression. Am. J. Psychiatry 162: 1351-1360 [Abstract] [Full text]
Steinman, M. A., Gonzales, R., Linder, J. A., Landefeld, C. S. (2003). Changing Use of Antibiotics in Community-Based Outpatient Practice, 1991-1999. ANN INTERN MED 138: 525-533 [Abstract] [Full text]
Schroeder, K., Ebrahim, S., Fahey, T., Montgomery, A., Peters, T., Lask, B., Porter, A. (2002). Daily regimen and compliance with treatment. BMJ 324: 425-425 [Full text]

Rapid Responses:

Read all Rapid Responses

Drug regimens and compliance: Alan M W Porter
bmj.com, 24 Sep 2001 [Full text]
Self-evident?: Dominic McDermott
bmj.com, 24 Sep 2001 [Full text]
Was Bloom's article and editorial or an advertisement?: Patrick Vallance
bmj.com, 25 Sep 2001 [Full text]
Compliance with treatment for tuberculosis: Graham F Cope, et al.
bmj.com, 3 Oct 2001 [Full text]
Conflicting evidence for effect of dosing schedules on compliance: Knut Schroeder
bmj.com, 4 Oct 2001 [Full text]
Low-dose thiazide diuretics and beta-blockers are as well tolerated as the newer antihypertensives: Briegeen Girvin
bmj.com, 25 Oct 2001 [Full text]
Evidence that newer drugs improve compliance is biased: Peter Jackson
bmj.com, 26 Oct 2001 [Full text]